Lattmann E, Billington D C, Poyner D R, Howitt S B, Offel M
Pharmaceutical Sciences Research Institute, School of Life and Health Sciences, Aston University, Birmingham, UK.
Drug Des Discov. 2001;17(3):219-30.
The SAR of Asperlicin analogues is reported, leading to bioactive 1,4-benzodiazepine-2-ones, which were prepared in a 3 step reaction sequence. The Asperlicin substructure was built up using Tryptophan and readily available 2-amino-acetophenones. This template, containing a 1,4-benzodiazepin-2-one moiety with a 3-indolmethyl side chain, was transformed into mono- and di-substituted 3-indol-3'-yl-methyl-1,4-benzodi-azepine-2-ones by selective alkylation and acylation reactions. The SAR optimization of the 1,4-benzodiazepine scaffold has included variations at the 5-, 7-, 8-position, at the N1, N-indole nitrogen and the configuration of the C3-position. The most active Asperlicin analogue, having an IC50 of 1.6 microM on the CCKA receptor subtype, was obtained from Tryptophan in only 3 steps in an overall yield of 48%.
报道了阿斯匹林类似物的构效关系,得到了具有生物活性的1,4-苯并二氮杂䓬-2-酮,其通过三步反应序列制备。使用色氨酸和容易获得的2-氨基苯乙酮构建了阿斯匹林亚结构。这个包含带有3-吲哚甲基侧链的1,4-苯并二氮杂䓬-2-酮部分的模板,通过选择性烷基化和酰化反应转化为单取代和双取代的3-吲哚-3'-基甲基-1,4-苯并二氮杂䓬-2-酮。1,4-苯并二氮杂䓬支架的构效关系优化包括在5-、7-、8-位、N1、N-吲哚氮以及C3-位构型上的变化。最具活性的阿斯匹林类似物,对CCKA受体亚型的IC50为1.6微摩尔,仅通过三步从色氨酸获得,总收率为48%。